120 related articles for article (PubMed ID: 38105508)
1. Gynaecological organ involvement in females undergoing radical cystectomy: a multicentre study.
Lobo N; Uthayanan L; Uribe-Lewis S; Issa R; Tay A; Thurairaja R; Nair R; Khan MS; Kusuma M; Abou Chedid W; Moschonas D; Woodhams S; Swinn M; Patil K; Perry M
BJU Int; 2024 Apr; 133(4):474-479. PubMed ID: 38105508
[TBL] [Abstract][Full Text] [Related]
2. Contemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy.
Bree KK; Hensley PJ; Westerman ME; Kokorovic A; Nogueras-Gonzalez GM; Dinney CP; Kamat AM; Navai N
J Urol; 2021 Sep; 206(3):577-585. PubMed ID: 33872050
[TBL] [Abstract][Full Text] [Related]
3. Gynecologic Organ Involvement During Radical Cystectomy for Bladder Cancer: Is It Time to Routinely Spare the Ovaries?
Taylor BL; Matrai CE; Smith AL; Ayangbesan A; Xia L; Golombos DM; Mosquera JM; Nicolas J; Robinson BD; Scherr DS; Khani F
Clin Genitourin Cancer; 2019 Feb; 17(1):e209-e215. PubMed ID: 30470630
[TBL] [Abstract][Full Text] [Related]
4. Reproductive organ involvement in female patients undergoing radical cystectomy for urothelial bladder cancer.
Djaladat H; Bruins HM; Miranda G; Cai J; Skinner EC; Daneshmand S
J Urol; 2012 Dec; 188(6):2134-8. PubMed ID: 23083874
[TBL] [Abstract][Full Text] [Related]
5. Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome.
Turker P; Bostrom PJ; Wroclawski ML; van Rhijn B; Kortekangas H; Kuk C; Mirtti T; Fleshner NE; Jewett MA; Finelli A; Kwast TV; Evans A; Sweet J; Laato M; Zlotta AR
BJU Int; 2012 Sep; 110(6):804-11. PubMed ID: 22321341
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy.
Seisen T; Jamzadeh A; Leow JJ; Rouprêt M; Cole AP; Lipsitz SR; Kibel AS; Nguyen PL; Sun M; Menon M; Bellmunt J; Choueiri TK; Trinh QD
JAMA Oncol; 2018 Feb; 4(2):225-229. PubMed ID: 28837718
[TBL] [Abstract][Full Text] [Related]
7. Dose dense MVAC prior to radical cystectomy: a real-world experience.
Zargar H; Shah JB; van de Putte EEF; Potvin KR; Zargar-Shoshtari K; van Rhijn BW; Daneshmand S; Holzbeierlein JM; Spiess PE; Winquist E; Horenblas S; Dinney C; Black PC; Kassouf W
World J Urol; 2017 Nov; 35(11):1729-1736. PubMed ID: 28625005
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of short-term outcomes of neoadjuvant chemotherapy followed by radical cystectomy in muscle-invasive bladder cancer: a single Egyptian institution experience.
Abdelrahman I; Aboulkassem H; Elazab A; Abdallah AY; Ismail Y; Taher M
J Egypt Natl Canc Inst; 2023 May; 35(1):13. PubMed ID: 37145329
[TBL] [Abstract][Full Text] [Related]
9. Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer.
Hermans TJN; Voskuilen CS; Deelen M; Mertens LS; Horenblas S; Meijer RP; Boormans JL; Aben KK; van der Heijden MS; Pos FJ; de Wit R; Beerepoot LV; Verhoeven RHA; van Rhijn BWG
Int J Cancer; 2019 Mar; 144(6):1453-1459. PubMed ID: 30155893
[TBL] [Abstract][Full Text] [Related]
10. Secondary malignant involvement of gynecologic organs in radical cystectomy specimens in women: is it mandatory to remove these organs routinely?
Ali-El-Dein B; Abdel-Latif M; Mosbah A; Eraky I; Shaaban AA; Taha NM; Ghoneim MA
J Urol; 2004 Sep; 172(3):885-7. PubMed ID: 15310990
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.
Vetterlein MW; Wankowicz SAM; Seisen T; Lander R; Löppenberg B; Chun FK; Menon M; Sun M; Barletta JA; Choueiri TK; Bellmunt J; Trinh QD; Preston MA
Cancer; 2017 Nov; 123(22):4346-4355. PubMed ID: 28743155
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness of Treatment Strategies for Squamous Cell Carcinoma of the Bladder.
Stensland KD; Zaid H; Broadwin M; Sorcini A; Canes D; Galsky M; Moinzadeh A
Eur Urol Oncol; 2020 Aug; 3(4):509-514. PubMed ID: 31411987
[TBL] [Abstract][Full Text] [Related]
13. NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder.
Potretzke A; Hillman L; Wong K; Shi F; Brower R; Mai S; Cetnar JP; Abel EJ; Downs TM
Urol Oncol; 2014 Jul; 32(5):631-6. PubMed ID: 24629498
[TBL] [Abstract][Full Text] [Related]
14. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
[TBL] [Abstract][Full Text] [Related]
15. Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.
Hermans TJ; Fransen van de Putte EE; Horenblas S; Meijer RP; Boormans JL; Aben KK; van der Heijden MS; de Wit R; Beerepoot LV; Verhoeven RH; van Rhijn BW
Eur J Cancer; 2016 Dec; 69():1-8. PubMed ID: 27814469
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation.
Zargar-Shoshtari K; Sverrisson EF; Sharma P; Gupta S; Poch MA; Pow-Sang JM; Spiess PE; Sexton WJ
Clin Genitourin Cancer; 2016 Feb; 14(1):82-8. PubMed ID: 26411593
[TBL] [Abstract][Full Text] [Related]
17. Oncological impact of inflammatory biomarkers in elderly patients treated with radical cystectomy for urothelial bladder cancer.
Mari A; Muto G; Di Maida F; Tellini R; Bossa R; Bisegna C; Campi R; Cocci A; Viola L; Grosso A; Scelzi S; Lapini A; Carini M; Minervini A
Arab J Urol; 2020 Aug; 19(1):2-8. PubMed ID: 33763243
[TBL] [Abstract][Full Text] [Related]
18. Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Kluth LA; Xylinas E; Rieken M; El Ghouayel M; Sun M; Karakiewicz PI; Lotan Y; Chun FK; Boorjian SA; Lee RK; Briganti A; Rouprêt M; Fisch M; Scherr DS; Shariat SF
BJU Int; 2014 Mar; 113(3):393-8. PubMed ID: 24053618
[TBL] [Abstract][Full Text] [Related]
19. Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.
Hwang EC; Sathianathen NJ; Imamura M; Kuntz GM; Risk MC; Dahm P
Cochrane Database Syst Rev; 2019 May; 5(5):CD013336. PubMed ID: 31111956
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis.
Soria F; Black PC; Fairey AS; Cookson MS; Yu EY; Kassouf W; Dall'Era MA; Sridhar SS; McGrath JS; Wright JL; Thorpe AC; Morgan TM; Daneshmand S; Holzbeierlein JM; Bivalacqua TJ; North S; Barocas DA; Lotan Y; Grivas P; Stephenson AJ; Shah JB; van Rhijn BW; Spiess PE; Shariat SF; Gontero P
BJU Int; 2021 Jul; 128(1):79-87. PubMed ID: 33152179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]